The Center for Professional Innovation and Education (CfPIE) announces the addition of two new training courses to its roster of 200 current course offerings
These new courses, 'Adme, PK/TK, and drug metabolism in drug discovery and development' and 'Developability assessment - the logical approach to discovery lead selection' have been developed and will be taught by Dr Duane Lakings.
Lakings has over 25 years of experience in drug discovery and developability assessment, preclinical and non-clinical development, and clinical development and has designed and conducted animal and human research studies on both small organic molecules and macromolecules.
His primary areas of expertise include pharmacokinetics and toxicokinetics, drug metabolism and Adme, drug delivery, and bioanalytical chemistry and he has excellent knowledge of the pharmacology, toxicology, and clinical requirements for successful drug development.
CfPIE's educational conferences are designed to address the latest issues affecting R+D, manufacturing and regulatory affairs topics in the pharmaceutical, biotech, medical device and skin/cosmetic industries.
Training provided by CfPIE has been utilized by over 600 corporations, federal and state governments and numerous non-profit agencies.
A number of these organizations have designated CfPIE as their primary provider of external training.
"We have been consistently ranked as one of the premier providers of training and educational services with both our extensive public course schedule and our customized on-site programs" said Mark Mazzie, managing director.
"In addition to the 140 public programmes scheduled in North America and Europe during 2005, we will deliver over 150 on-site programs designed to meet the specific needs of our clients." Mazzie stated: "We are very pleased to welcome Dr Lakings to our organization.
"His reputation and industry experience are a valuable addition to CfPIE.
"Dr Lakings is the seventh course director hired over the last eighteen months.
"The addition of carefully chosen, high quality course directors will further enhance our standing as the premier provider of educational services to pharmaceutical, biotech, medical device and skin/cosmetic professionals worldwide."
